Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2025-12-16 @ 11:13 PM
Study NCT ID:
NCT06264180
Status:
None
Last Update Posted:
2025-09-22 00:00:00
First Post:
2024-01-29 00:00:00
Brief Title:
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Sponsor:
Replimune Inc
Organization:
Replimune Inc.
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-29 00:00:00
First Submit QC Date:
February 9 2024
Study First Post Date:
2024-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17 00:00:00
Last Update Post Date:
2025-09-22 00:00:00
Last Update Post Date Type:
ESTIMATED